Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment

Authors: Massimo Confortini, Francesca Carozzi, Marco Zappa, Leonardo Ventura, Anna Iossa, Paola Cariaggi, Livia Brandigi, Mario Franchini, Francesco Mirri, Paolo Viacava, Aurora Scarfantoni, Daniela Bazzanti, Cristina Sani

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

There is conclusive evidence that human papillomavirus (HPV) infections of the cervix are a necessary cause of cervical cancer. In Italy there are consistent data of HPV prevalence in women aged 25 - 64 years, but there is limited data for younger women. The objective of this on-going 3-year prospective cohort study is to investigate the prevalence, acquisition, clearance and persistence of HPV infections in young Tuscan women and the risk factors correlated with such events.

Methods

One thousand and sixty-six women aged between 18 and 24 years were enrolled and received an initial HPV test. They were asked to return to the clinic over the study period for further tests every 12 months, if their HPV HR result was negative, or every 6 months, if positive. Additionally, women with an HPV positive result were given a cytological examination and if the cytological diagnosis was ASC-US or more severe, only women with HPV HR, were referred for colposcopy.

Results

We present here data for the enrolment phase of the study. At baseline, within the study sample, just under 30% of women were infected by HPV and 19.3% of women were infected with oncogenic types. A relationship was highlighted between HPV infection, number of sexual partners (in particularly in the last 3 years) and the lifetime number of partner's partners. Condom use showed a slight protective effect in univariate analysis but these data were not statistically significant in multivariate analysis. The association between HPV infection and demographic and behavioural variables were tested by crude odds ratio (OR). Multivariate logistic regression was applied to compute the adjusted odds ratios.

Conclusions

The prevalence of oncogenic HPV types was high in young Tuscan women. The 3-year follow-up of this cohort may provide a better understanding of the processes of acquisition, clearance and persistence of infection and the correlated risk factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, the International Biological Study on Cervical Cancer (IBSCC) Study Group: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst (Bethesda). 1995, 87: 796-802.CrossRef Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, the International Biological Study on Cervical Cancer (IBSCC) Study Group: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst (Bethesda). 1995, 87: 796-802.CrossRef
2.
go back to reference Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.CrossRefPubMed
3.
go back to reference Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh TM, Palefsky J: Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. J Am Med Ass. 2001, 85: 2995-3002. 10.1001/jama.285.23.2995.CrossRef Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh TM, Palefsky J: Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. J Am Med Ass. 2001, 85: 2995-3002. 10.1001/jama.285.23.2995.CrossRef
4.
go back to reference Hildesheim A, Schiffman M, Gravitt P, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manes MM: Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994, 169: 235-240.CrossRefPubMed Hildesheim A, Schiffman M, Gravitt P, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manes MM: Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994, 169: 235-240.CrossRefPubMed
5.
go back to reference Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G: Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 1993, 82: 578-585. 10.1097/00006250-199310000-00021.PubMed Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G: Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 1993, 82: 578-585. 10.1097/00006250-199310000-00021.PubMed
6.
go back to reference Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer Working Group: Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006, 98 (11): 765-74. 10.1093/jnci/djj209.CrossRefPubMed Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer Working Group: Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006, 98 (11): 765-74. 10.1093/jnci/djj209.CrossRefPubMed
7.
go back to reference Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer screening Working Group: Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 2006, 7 (7): 547-55. 10.1016/S1470-2045(06)70731-8.CrossRefPubMed Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer screening Working Group: Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 2006, 7 (7): 547-55. 10.1016/S1470-2045(06)70731-8.CrossRefPubMed
8.
go back to reference Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A: Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev. 2008, 17 (8): 2002-6. 10.1158/1055-9965.EPI-08-0180.CrossRefPubMed Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A: Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev. 2008, 17 (8): 2002-6. 10.1158/1055-9965.EPI-08-0180.CrossRefPubMed
9.
go back to reference Raccomandazioni per la pianificazione e l'esecuzione degli screening di popolazione per la prevenzione del cancro della mammella, del cancro della cervice uterina e del cancro del colon retto. Ministero della Salute. Roma. 2006 Raccomandazioni per la pianificazione e l'esecuzione degli screening di popolazione per la prevenzione del cancro della mammella, del cancro della cervice uterina e del cancro del colon retto. Ministero della Salute. Roma. 2006
10.
go back to reference Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E: Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol. 2004, 57 (1): 68-72. 10.1136/jcp.57.1.68.CrossRefPubMedPubMedCentral Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E: Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol. 2004, 57 (1): 68-72. 10.1136/jcp.57.1.68.CrossRefPubMedPubMedCentral
11.
go back to reference Tozetti IA, Scapulatempo ID, Kawski VL, Ferreira AW, Levi JE: Multiple types of human papillomavirus in cervical samples in women in Campo Grande, MS, Brazil. Braz J Infect Dis. 2006, 10 (5): 309-10. 10.1590/S1413-86702006000500001.CrossRefPubMed Tozetti IA, Scapulatempo ID, Kawski VL, Ferreira AW, Levi JE: Multiple types of human papillomavirus in cervical samples in women in Campo Grande, MS, Brazil. Braz J Infect Dis. 2006, 10 (5): 309-10. 10.1590/S1413-86702006000500001.CrossRefPubMed
12.
go back to reference Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N, Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002, 287: 2114-2119. 10.1001/jama.287.16.2114.CrossRefPubMed Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N, Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002, 287: 2114-2119. 10.1001/jama.287.16.2114.CrossRefPubMed
13.
go back to reference Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, Kiviat NB: Human papillomavirus infection among sexually active women in the United States : implications for developing a vaccination strategy. Sex transm Dis. 2006, 33: 502-8. 10.1097/01.olq.0000204545.89516.0a.CrossRefPubMed Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, Kiviat NB: Human papillomavirus infection among sexually active women in the United States : implications for developing a vaccination strategy. Sex transm Dis. 2006, 33: 502-8. 10.1097/01.olq.0000204545.89516.0a.CrossRefPubMed
14.
go back to reference Winer Rl, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA: Genital human papillomavirus infection: invcidence and risk factors in a cohort of female university student. Am J Epidemiol. 2003, 157: 218-26. 10.1093/aje/kwf180.CrossRefPubMed Winer Rl, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA: Genital human papillomavirus infection: invcidence and risk factors in a cohort of female university student. Am J Epidemiol. 2003, 157: 218-26. 10.1093/aje/kwf180.CrossRefPubMed
15.
go back to reference Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N, New Technologies for Cervical Cancer Screening Working Group: Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008, 100 (7): 492-501. 10.1093/jnci/djn065.CrossRefPubMed Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N, New Technologies for Cervical Cancer Screening Working Group: Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008, 100 (7): 492-501. 10.1093/jnci/djn065.CrossRefPubMed
16.
go back to reference Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M: Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol. 2009, 81 (2): 271-7. 10.1002/jmv.21382.CrossRefPubMed Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M: Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol. 2009, 81 (2): 271-7. 10.1002/jmv.21382.CrossRefPubMed
17.
go back to reference Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, Gheit T, Tommasino M: Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine. 2009, 27 (Suppl 1): A30-3. 10.1016/j.vaccine.2008.12.028.CrossRefPubMed Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, Gheit T, Tommasino M: Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine. 2009, 27 (Suppl 1): A30-3. 10.1016/j.vaccine.2008.12.028.CrossRefPubMed
18.
go back to reference Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY: Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res. 2008, 68 (21): 8813-24. 10.1158/0008-5472.CAN-08-1380.CrossRefPubMedPubMedCentral Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY: Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res. 2008, 68 (21): 8813-24. 10.1158/0008-5472.CAN-08-1380.CrossRefPubMedPubMedCentral
19.
go back to reference Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, Koutsky LA: Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis. 2000, 182 (4): 1097-102. 10.1086/315805.CrossRefPubMed Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, Koutsky LA: Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis. 2000, 182 (4): 1097-102. 10.1086/315805.CrossRefPubMed
20.
go back to reference Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ, Ronderos M, Meijer C, Munoz A, Instituto Nacional de Cancerologia Human Papillomavirus Study Group: Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis. 2005, 192 (7): 1158-65. 10.1086/444391.CrossRefPubMed Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ, Ronderos M, Meijer C, Munoz A, Instituto Nacional de Cancerologia Human Papillomavirus Study Group: Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis. 2005, 192 (7): 1158-65. 10.1086/444391.CrossRefPubMed
21.
go back to reference Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL: Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis. 2001, 184 (12): 1508-17. 10.1086/324579.CrossRefPubMed Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL: Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis. 2001, 184 (12): 1508-17. 10.1086/324579.CrossRefPubMed
22.
go back to reference Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, Koutsky LA: Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006, 354 (25): 2645-54. 10.1056/NEJMoa053284.CrossRefPubMed Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, Koutsky LA: Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006, 354 (25): 2645-54. 10.1056/NEJMoa053284.CrossRefPubMed
23.
go back to reference Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of a cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338: 423-8. 10.1056/NEJM199802123380703.CrossRefPubMed Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of a cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338: 423-8. 10.1056/NEJM199802123380703.CrossRefPubMed
24.
go back to reference Moscicki AB, Schiffman m, Kjaer S, Villa LL: Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006, 24 (Suppl 3): S42-51. 10.1016/j.vaccine.2006.06.018.CrossRef Moscicki AB, Schiffman m, Kjaer S, Villa LL: Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006, 24 (Suppl 3): S42-51. 10.1016/j.vaccine.2006.06.018.CrossRef
25.
go back to reference Karlsonn R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, Rylander E, Wadell G: Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population based study. Sex Transm Dis. 1995, 22: 119-27. 10.1097/00007435-199503000-00008.CrossRef Karlsonn R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, Rylander E, Wadell G: Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population based study. Sex Transm Dis. 1995, 22: 119-27. 10.1097/00007435-199503000-00008.CrossRef
26.
go back to reference Vaccarella S, Herrero R, Snijders PJ, Dai M, Thomas JO, Hieu NT, Ferreccio C, Matos E, Posso H, de Sanjosé S, Shin HR, Sukvirach S, Lazcano-Ponce E, Muñoz N, Meijer CJ, Franceschi S, IARC HPV Prevalence Surveys (IHPS) Study Group: Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol. 2008, 37 (3): 536-46. 10.1093/ije/dyn033. Epub 2008 Mar 3CrossRefPubMed Vaccarella S, Herrero R, Snijders PJ, Dai M, Thomas JO, Hieu NT, Ferreccio C, Matos E, Posso H, de Sanjosé S, Shin HR, Sukvirach S, Lazcano-Ponce E, Muñoz N, Meijer CJ, Franceschi S, IARC HPV Prevalence Surveys (IHPS) Study Group: Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol. 2008, 37 (3): 536-46. 10.1093/ije/dyn033. Epub 2008 Mar 3CrossRefPubMed
27.
go back to reference Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338: 423-8. 10.1056/NEJM199802123380703.CrossRefPubMed Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338: 423-8. 10.1056/NEJM199802123380703.CrossRefPubMed
28.
go back to reference Davidson M, Schnitzer PG, Bulkow LR, Parkinson AJ, Schloss ML, Fitzgerald MA, Knight JA, Murphy CM, Kiviat NB, Toomey KE: The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis. 1994, 169: 792-800.CrossRefPubMed Davidson M, Schnitzer PG, Bulkow LR, Parkinson AJ, Schloss ML, Fitzgerald MA, Knight JA, Murphy CM, Kiviat NB, Toomey KE: The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis. 1994, 169: 792-800.CrossRefPubMed
29.
go back to reference Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM: Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis. 1995, 22: 236-43. 10.1097/00007435-199507000-00007.CrossRefPubMed Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM: Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis. 1995, 22: 236-43. 10.1097/00007435-199507000-00007.CrossRefPubMed
30.
go back to reference Young TK, McNicol P, Beauvais J: Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian Aboriginal and non-Aboriginal women. Sex Transm Dis. 1997, 24: 293-8. 10.1097/00007435-199705000-00011.CrossRefPubMed Young TK, McNicol P, Beauvais J: Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian Aboriginal and non-Aboriginal women. Sex Transm Dis. 1997, 24: 293-8. 10.1097/00007435-199705000-00011.CrossRefPubMed
31.
go back to reference Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ: Human papillomavirus infection in Danish female sex workers: decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis. 2000, 27 (4): 38-45. Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ: Human papillomavirus infection in Danish female sex workers: decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis. 2000, 27 (4): 38-45.
Metadata
Title
Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment
Authors
Massimo Confortini
Francesca Carozzi
Marco Zappa
Leonardo Ventura
Anna Iossa
Paola Cariaggi
Livia Brandigi
Mario Franchini
Francesco Mirri
Paolo Viacava
Aurora Scarfantoni
Daniela Bazzanti
Cristina Sani
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-157

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.